Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Hong Kong Buybacks: AIA, Xiaomi, Ping An H&T

Hong Kong Buybacks: Tencent Led the 52 Week High Buybacks

Hong Kong Buybacks: Tencent Continued HKD 300m Daily Buyback

Hong Kong Buybacks: Man Wah, China Gas, Hysan

Hong Kong Buybacks: China Gas, China Mobile, Pop Mart

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyze statistics on top repurchases over one week, one month, one quarter and one year periods ended on Mar 18 based on HKEx daily reports.</li>
<li>In the past 7 days, the top 3 companies that repurchased the most shares from the market were Concord New Energy, Ping An H&amp;T, Imax China.</li>
<li>In the past 30 days, the top 3 companies that repurchased the most shares from the market were China Gas (384 HK), China Mobile (941 HK), Man Wah (1999 HK).</li>
</ul>


We analyze statistics on top repurchases over one week, one month, one quarter and one year periods ended on Mar 18 based on HKEx daily reports.
In the past 7 days, the top 3 companies that repurchased the most shares from the market were Concord New Energy, Ping An H&amp;T, Imax China.
In the past 30 days, the top 3 companies that repurchased the most shares from the market were China Gas (384 HK), China Mobile (941 HK), Man Wah (1999 HK).


Ping An Healthcare and Technology (1833 HK)

Hong Kong Buybacks: Concord New Energy, Ping An H&T, Imax China